PLUS1
Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last $ 7.70 ▲ 0.17 (2.19%) | |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Protagonist Therapeutics Inc | PTGX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.095 | -1.25% | 7.535 | 7.71 | 7.41 | 7.60 | 7.63 | 20:00:00 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 7.24 | 8.00 | 0.76 | 9.5% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,967 | 426,555 | $ 7.60 | $ 3,240,406 | 1,125,262 | 4.47 - 16.67 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:40:22 | 94 | $ 7.70 | USD |
Protagonist Therapeutics Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 205.00M | 27.21M | $ -38.92M | -1.74 | - | 26.67M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 1.00 | 2.00% |
Protagonist Therapeutics News
| Date | Time | Source | News Article |
|---|---|---|---|
| 12/03/2019 | 18:46 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 12/03/2019 | 18:33 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 12/03/2019 | 18:12 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 12/03/2019 | 18:11 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 12/03/2019 | 07:51 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 12/03/2019 | 07:00 | PR Newswire (US) | Protagonist Therapeutics Announces Preliminary Phase 2.. |
| 11/27/2019 | 17:20 | Edgar (US Regulatory) | Current Report Filing (8-k) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PTGX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 7.82 | 8.98 | 4.47 | 7.48 | 5,083,290 | -0.285 | -3.64% |
| 1 Month | 10.56 | 10.97 | 4.47 | 7.83 | 1,662,806 | -3.03 | -28.65% |
| 3 Months | 14.75 | 15.19 | 4.47 | 8.58 | 649,213 | -7.22 | -48.92% |
| 6 Months | 11.56 | 16.67 | 4.47 | 9.79 | 433,566 | -4.03 | -34.82% |
| 1 Year | 6.61 | 16.67 | 4.47 | 9.89 | 299,663 | 0.925 | 13.99% |
| 3 Years | 21.81 | 23.97 | 4.47 | 10.70 | 196,469 | -14.28 | -65.45% |
| 5 Years | 12.00 | 26.3598 | 4.47 | 11.00 | 186,187 | -4.47 | -37.21% |
Protagonist Therapeutics Description
| Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidate to address medical needs. |
